(19)
(11) EP 2 707 025 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.08.2017 Bulletin 2017/34

(45) Mention of the grant of the patent:
12.07.2017 Bulletin 2017/28

(21) Application number: 12785009.7

(22) Date of filing: 14.05.2012
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
A61K 39/155(2006.01)
(86) International application number:
PCT/US2012/037839
(87) International publication number:
WO 2012/158643 (22.11.2012 Gazette 2012/47)

(54)

HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS

IMMUNOGENE HENDRA- UND NIPAH-VIRUS-G-GLYCOPROTEIN-ZUSAMMENSETZUNGEN

COMPOSITIONS IMMUNOGÈNES CONTRE LA GLYCOPROTÉINE G DES VIRUS HENDRA ET NIPAH


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 13.05.2011 US 201161485992 P

(43) Date of publication of application:
19.03.2014 Bulletin 2014/12

(60) Divisional application:
17180615.1

(73) Proprietors:
  • Zoetis Services LLC
    Parsippany, NJ 07054 (US)
  • HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
    Bethesda, MD 20817 (US)

(72) Inventors:
  • ELHAY, Martin
    Yarraville, Victoria 3013 (AU)
  • BRODER, Christopher, C.
    Bethesda, MD 20817 (US)
  • HUANG, Jin-An
    Box Hill North, VIC 3129 (AU)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
WO-A2-2006/115548
US-A1- 2007 150 972
US-A1- 2010 278 862
US-A1- 2002 081 329
US-A1- 2009 041 772
   
  • B. A. MUNGALL ET AL: "Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine", JOURNAL OF VIROLOGY, vol. 80, no. 24, 27 September 2006 (2006-09-27), pages 12293-12302, XP055151022, ISSN: 0022-538X, DOI: 10.1128/JVI.01619-06
  • MCEACHERN J A ET AL: "A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats", VACCINE, ELSEVIER LTD, GB, vol. 26, no. 31, 23 July 2008 (2008-07-23) , pages 3842-3852, XP022822176, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2008.05.016 [retrieved on 2008-06-02]
  • YU ET AL.: 'The Attachment Protein of Hendra Virus Has High Structural Similarity but Limited Primary Sequence Homology Compared with Viruses in the Genus Paramyxovirus' VIROLOGY vol. 251, 1998, pages 227 - 233, XP026881432
  • DATABASE UNIPROT. [Online] 05 April 2011 YU ET AL., XP003032834 Database accession no. O89343
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).